[Aspergillus lentulus in a patient with cryptogenic organizing pneumonia treated with oral corticosteroids] [0.03%]
一名接受口服皮质类固醇治疗特发性机化性肺炎患者的曲霉菌lentulus病原感染病例报告
Gonzalo Segrelles Calvo,Estefanía Llopis Pastor,Esther Antón et al.
Gonzalo Segrelles Calvo et al.
[Management of Interstitial Lung Diseases (ILD) Associated with Autoimmune Diseases by the Pulmonologyst in the Differents ILD Units in Spain] [0.03%]
[西班牙不同间质性肺疾病单位中呼吸科医生管理与自身免疫性疾病相关的间质性肺疾病(ILD)]
Orlando Acosta Fernández,Myriam Aburto Barrenetxea,Ana Belén Llanos González et al.
Orlando Acosta Fernández et al.
Introduction: The aim of the study was to know the management of patients with diffuse interstitial lung disease (ILD) associated with a systemic autoimmune diseases (SAD) in pulmonology outpatient clinics in Spain. ...
[How to Approach Non Eosinophilic Asthma? Results of a Survey Conducted by the SEPAR Emerging Asthma Group] [0.03%]
非嗜酸性哮喘如何处理？西班牙新兴哮喘组的一项调查结果
Elena Curto Sánchez,Íñigo Ojanguren Arranz,Marina Blanco-Aparicio et al.
Elena Curto Sánchez et al.
Pertussis Vaccine in COPD and Asthma: An Old Acquaintance Is Back [0.03%]
慢性阻塞性肺疾病和哮喘患者的百日咳疫苗：一位老朋友回来了
Felipe Villar-Álvarez,Francisco-Javier González-Barcala,Pedro José Bernal-González
Felipe Villar-Álvarez
María Rosa Güell Rous
María Rosa Güell Rous
Pulmonary rehabilitation (PR) has been seen to be useful not only in chronic obstructive pulmonary disease, but also in other non-chronic obstructive pulmonary disease respiratory diseases. It is highly effective in improving dyspnea, exerc...
Fernando Revuelta-Salgado,Rocío Magdalena Díaz-Campos,Ascensión Hernando-Sanz et al.
Fernando Revuelta-Salgado et al.
[This is the time] [0.03%]
这是时刻了
Luis Puente-Maestú
Luis Puente-Maestú
[Importance of Contrast-Enhanced CT in the Early Diagnosis of Pulmonary Mucormycosis: A Case Report] [0.03%]
关于对比剂增强CT在肺曲霉病早期诊断中重要性的病例报告
Marta Porta Vilaró,Sebastián Capurro,Daniel Martínez et al.
Marta Porta Vilaró et al.
[Multidisciplinary Consensus for the Monitoring and Control of Asthma Through Telemedicine. The COMETA Project] [0.03%]
基于远程医疗的哮喘监测与控制多学科专家共识(Cometa项目)
Carlos Almonacid Sánchez,Marina Blanco Aparicio,Javier Domínguez Ortega et al.
Carlos Almonacid Sánchez et al.
Despite the therapeutic advances currently available, asthma control is poor. Such control is based on assessing the patient, adjusting treatment, and reviewing the response to treatment. In normal situations, asthma is monitored and contro...
[The Effectiveness of Mepolizumab and Benralizumab in a Real-Life Cohort of Patients with Severe Eosinophilic Asthma] [0.03%]
Mepolizumab和Benralizumab治疗重度嗜酸粒细胞性哮喘真实世界队列的有效性研究
María José Espinosa de Los Monteros Garde,Víctor Romero Sanz,Cristina Blázquez Romero
María José Espinosa de Los Monteros Garde
Introduction: Mepolizumab is a monoclonal antibody that inhibits circulating interleukin 5 (IL-5). Benralizumab binds to the alpha subunit of the IL-5 receptor, inducing the direct elimination of eosinophils and basophils...